Rare and life-threatening pregnancy combated with surgery
The procedure not only saved the mother's life but also ensured the safe birth of her child, setting a record in maternal healthcare, according to hospital superintendent Durgaprasad M.R.
The woman was born with Haemophilia (Von Willebrand's disease), a hereditary bleeding disorder. She had been receiving treatment at private hospitals since childhood.
Haemophilia, characterised by a deficiency of Factor 8, plays a critical role in blood clotting. Without proper management, bleeding episodes can be severe and life-threatening. The specific Factor 8 replacement therapy must be administered continuously through injections, which are costly and not easily accessible.
Unfortunately, such rare conditions pose significant challenges, especially when treatment options are expensive and limited.
The plasma-derived Factor 8 injections are expensive, and many families find it difficult to afford ongoing treatment. During her pregnancy, the woman's family was unable to bear the high costs of the required medication, which put her at risk of severe bleeding or even maternal death.In this critical scenario, the medical team provided confidential counselling, explaining the gravity of her condition.
Despite various family constraints, the woman was determined to deliver her baby and become a mother. The doctors accepted the challenge and successfully performed the delivery, saving her life.
Dr. Durgaprasad explained that he maintained continuous contact with the blood bank at Venlak Hospital and, with the support and approval of senior health department officials, arranged for the woman to receive the necessary injections weekly. This treatment was continued throughout her pregnancy.
Twenty days before her delivery date, the woman was admitted to the hospital. The hospital ensured the availability of Factor VIII (8) injections—totalling 25,000 units—sourced and supplied by the government.
The surgical team, comprising expert obstetricians and gynaecologists including Dr. Anupama Rao, Dr. Siriganesh, Dr. Namita, Dr. Sumeesh Rao, and Dr. Ranjan, along with anesthesia specialists, performed the Caesarean section successfully. Postoperative care was provided for ten days, after which the woman was discharged in good health and has since returned home.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
22-06-2025
- Hans India
ICMR's affordable test kits boost diagnosis of genetic blood disorders in India
New Delhi: Simple and affordable point-of-care (POC) test kits, developed by scientists at the Indian Council of Medical Research (ICMR), are enhancing the diagnosis of genetic blood disorders like Haemophilia A, von Willebrand disease (VWD) and sickle cell disease (SCD) in the country. Haemophilia A, VWD, and SCD are serious inherited bleeding disorders, which often go undiagnosed because the testing is expensive and only available at a few specialised hospitals. India bears a significant burden from Haemophilia A. Estimates suggest around 136,000 individuals are affected, but only a small fraction are diagnosed and registered. While the prevalence of VWD in India is estimated at 1 per 12,000 in some regions, limited studies suggest a 10 per cent prevalence among inherited bleeding disorders. In the case of SCD, the disease is particularly prevalent in India, especially among the tribal population (57 per cent), though it also affects non-tribals (43 per cent). 'We have now multiple tests that are made in India and can diagnose blood disorders. That is something we all should be proud of,' Dr Manisha Madkaikar, Director, ICMR-Centre for Research, Management, and Control of Haemoglobinopathies (CRMCH) in Chandrapur district of Maharashtra, told IANS. ICMR-National Institute of Immunohaematology (NIIH) developed a POC test kit for diagnosing Haemophilia A, VWD, which can also be used at primary health centres (PHCs), bringing diagnosis closer to the people who need it most. Notably, 'the POC test costs just Rs 582 per patient, while the current lab-based tests cost around Rs. 2,086. Using this kit could help detect over 83,000 undiagnosed cases,' Madkaikar said, adding that the kits can 'save the health system about Rs 42 crore -- three times cheaper than the current method'. These tests are being integrated into the national health programme at the PHC level in different states. 'Using the cost-effective POC kits at PHCs and other local health centres can help India find and treat bleeding disorders early, improve patient outcomes, and cut healthcare costs dramatically,' the senior scientist said. In addition, 'the World Federation for Hemophilia has also shown interest in procuring these tests for deployment in countries where the disease is prevalent,' Madkaikar said. Further, to support the fight against SCD, ICMR-NIIH in Mumbai and CRMCH in Chhattisgarh have been officially chosen by the government to test and approve new diagnostic kits. "So far, they have checked and approved 30 different kits, including simple tests that can be done on the spot (like finger-prick tests); lab-based tests like HPLC; and tests that detect the disease at the genetic level," said Madkaikar, adding that these test kits may play a key role in the national screening programme for SCD that targets a population of 7 crore in the country. While the initial manufacturer's quote for the diagnostic test was Rs 350 per test, a comprehensive analysis by ICMR determined that POC tests for sickle cell disease/trait among the high-risk population in India would be cost-effective if procured at Rs 100 per test or below. Subsequently, the new kits validated by ICMR-NIIH are priced below Rs 50 per test. 'When the national sickle cell elimination mission was to be launched, we had only two point of care tests, which were recommended under the nation, and both of them were paid outside, and the cost of that was nearly 350 rupees," Madkaikar said. "But now multiple indigenous companies have come up with their point of care test. We now have different tests, right from solubility to point-of-care to molecular -- all made in India and easily available," the scientist said.
Hans India
20-05-2025
- Hans India
Call for urgent need for genetic blood disorders awareness
Vijayawada: Minister for Health, Medical, and Family Welfare Y Satya Kumar Yadav on Monday stressed the critical need for increased public awareness regarding genetic blood disorders like Thalassemia, Sickle Cell Anaemia and Haemophilia. He was speaking at the inauguration of a two-day 'Orientation Training on Advanced Modalities in Diagnosis and Treatment of Blood Diseases' programme here on Monday, jointly organised by National Health Mission and Haemophilia Society, aims at equipping healthcare professionals with the latest knowledge in diagnosing and treating these conditions. The Minister highlighted the prevalence of these genetic disorders in the State, stating Andhra Pradesh has approximately 1,900 individuals suffering from Haemophilia, and roughly 2,100 people are battling Thalassemia, with a similar number affected by Sickle Cell Anaemia.' 'The State government is committed to identifying affected individuals and providing them with regular, free blood transfusions,' the Minister affirmed. He noted that five Integrated Centers for Hemoglobinopathy and Haemophilia (ICHH) across the State are already conducting preliminary diagnostic tests. Once a diagnosis is confirmed, the government provides free treatment and medicines. Beyond medical treatment, the State government is also providing a monthly pension of Rs 10,000 to those afflicted with Thalassemia, Sickle Cell Anaemia, and Haemophilia. Satya Kumar Yadav also provided an update on the ongoing Sickle Cell Anaemia screening programme in tribal areas, targeting individuals under 40 years old. 'Out of 1.9 million people requiring screening in these areas, we have screened 1.05 million so far, and the process is continuing,' he stated. He revealed that over 19,000 carriers have been identified, and 2,100 individuals have been diagnosed with the disease. Following genetic screening for Sickle Cell Anaemia, identification cards are being issued to those diagnosed. Minister Yadav also shared that Bhuvaneswari, wife of Chief Minister N Chandrababu Naidu, has undertaken a fundraising initiative in Vijayawada for Thalassemia patients. He mentioned the emergence of new technologies like gene editing, expressing confidence in the expertise of professors in government hospitals to provide high-quality services to economically disadvantaged patients. Dr Kameswara Prasad (APSACS APD in-charge), Dr Prasanna (Joint Director), Dr Devi (State Immunisation Officer), Dr NBSV Prasad (Secretary, Haemophilia Society Vijayawada Chapter), nodal officers for Sickle Cell Anaemia, nodal officers from the five ICHH centers, Dr Ramachandra Raju, Dr YD Ramarao, and other medical professionals also participated.
Hans India
19-05-2025
- Hans India
Rare and life-threatening pregnancy combated with surgery
Mangaluru: In a remarkable medical achievement, Lady Goschen Hospital successfully performed a surgical delivery on a pregnant woman suffering from a rare and potentially fatal blood disorder. The procedure not only saved the mother's life but also ensured the safe birth of her child, setting a record in maternal healthcare, according to hospital superintendent Durgaprasad M.R. The woman was born with Haemophilia (Von Willebrand's disease), a hereditary bleeding disorder. She had been receiving treatment at private hospitals since childhood. Haemophilia, characterised by a deficiency of Factor 8, plays a critical role in blood clotting. Without proper management, bleeding episodes can be severe and life-threatening. The specific Factor 8 replacement therapy must be administered continuously through injections, which are costly and not easily accessible. Unfortunately, such rare conditions pose significant challenges, especially when treatment options are expensive and limited. The plasma-derived Factor 8 injections are expensive, and many families find it difficult to afford ongoing treatment. During her pregnancy, the woman's family was unable to bear the high costs of the required medication, which put her at risk of severe bleeding or even maternal this critical scenario, the medical team provided confidential counselling, explaining the gravity of her condition. Despite various family constraints, the woman was determined to deliver her baby and become a mother. The doctors accepted the challenge and successfully performed the delivery, saving her life. Dr. Durgaprasad explained that he maintained continuous contact with the blood bank at Venlak Hospital and, with the support and approval of senior health department officials, arranged for the woman to receive the necessary injections weekly. This treatment was continued throughout her pregnancy. Twenty days before her delivery date, the woman was admitted to the hospital. The hospital ensured the availability of Factor VIII (8) injections—totalling 25,000 units—sourced and supplied by the government. The surgical team, comprising expert obstetricians and gynaecologists including Dr. Anupama Rao, Dr. Siriganesh, Dr. Namita, Dr. Sumeesh Rao, and Dr. Ranjan, along with anesthesia specialists, performed the Caesarean section successfully. Postoperative care was provided for ten days, after which the woman was discharged in good health and has since returned home.
